跳到主要內容

EcoR1 Capital, LLC

SEC CIK
0001587114
最新申報
2026/8/14

2021 年第 4 季持倉

持倉截至 2021/12/31,2022/2/14 申報。只含多頭部位,變化是跟 2021 年第 3 季比股數。

機構總覽
持股檔數
75
較 2021 年第 3 季 +6
總值
$31.2 億
較 2021 年第 3 季 +$2.92 億 (+10.3%)
申報日
2022/2/14
SEC
EcoR1 Capital, LLC 在 2021 年第 4 季的持倉
證券類別股數市值佔組合 %股數變化動作紀錄
PRTAProthena Corp Public Ltd CoSHS11,284,280$5.57 億17.8%00.0%不變歷史
ANABAnaptysbio, IncCOM7,521,024$2.61 億8.4%00.0%不變歷史
RCUSArcus Biosciences, Inc.COM5,523,358$2.24 億7.2%+400,999+7.8%加碼歷史
XNCRXencor IncCOM4,906,106$1.97 億6.3%00.0%不變歷史
APLSApellis Pharmaceuticals, Inc.COM4,033,882$1.91 億6.1%+4,033,882新進歷史
MORFMorphic Holding, Inc.COM3,951,566$1.87 億6.0%00.0%不變歷史
LKFTLakefront Biotherapeutics NVSPON ADR2,224,403$1.23 億3.9%+665,654+42.7%加碼歷史
NUVBNuvation Bio Inc.COM CL A13,896,543$1.18 億3.8%+185,026+1.3%加碼歷史
ALECAlector, Inc.COM4,994,970$1.03 億3.3%00.0%不變歷史
PTGXProtagonist Therapeutics, IncCOM2,639,706$9,028 萬2.9%+1,195,906+82.8%加碼歷史
CRSPCRISPR Therapeutics AGNAMEN AKT1,077,483$8,165 萬2.6%+1,077,483新進歷史
GRTSGritstone bio, Inc.COM6,012,232$7,732 萬2.5%+451,484+8.1%加碼歷史
ACADAcadia Pharmaceuticals IncCOM3,060,593$7,143 萬2.3%+3,060,593新進歷史
Avidity Biosciences, Inc.05370A108COM2,759,505$6,559 萬2.1%00.0%不變–
ITOSiTeos Therapeutics, Inc.COM1,303,157$6,068 萬1.9%00.0%不變歷史
RLAYRelay Therapeutics, Inc.COM1,779,084$5,464 萬1.7%+393,808+28.4%加碼歷史
KURAKura Oncology, Inc.COM3,724,437$5,214 萬1.7%00.0%不變歷史
ORICOric Pharmaceuticals, Inc.COM3,468,944$5,099 萬1.6%00.0%不變歷史
TSVT2seventy bio, Inc.COMMON STOCK1,917,063$4,913 萬1.6%+1,917,063新進歷史
AVIRAtea Pharmaceuticals, Inc.COM5,376,134$4,806 萬1.5%+5,376,134新進歷史
DSGNDesign Therapeutics, Inc.COM2,152,997$4,610 萬1.5%+289,899+15.6%加碼歷史
SAGESage Therapeutics, Inc.COM940,636$4,002 萬1.3%+940,636新進歷史
JANXJanux Therapeutics, Inc.COM1,411,975$2,786 萬0.9%00.0%不變歷史
PRDSPardes Biosciences, Inc.COM1,597,139$2,615 萬0.8%+1,597,139新進歷史
VTYXVentyx Biosciences, Inc.COM1,300,000$2,582 萬0.8%+1,300,000新進歷史
EWTXEdgewise Therapeutics, Inc.COM1,279,175$1,955 萬0.6%00.0%不變歷史
OVIDOvid Therapeutics Inc.COM6,082,200$1,952 萬0.6%00.0%不變歷史
AKUSAkouos, Inc.COM1,975,984$1,680 萬0.5%00.0%不變歷史
CRNXCrinetics Pharmaceuticals, Inc.COM590,169$1,677 萬0.5%+590,169新進歷史
ALNYAlnylam Pharmaceuticals, Inc.COM98,146$1,664 萬0.5%+98,146新進歷史
SLDBSolid Biosciences Inc.COM9,202,702$1,611 萬0.5%00.0%不變歷史
HALOHalozyme Therapeutics, Inc.COM392,000$1,576 萬0.5%+392,000新進歷史
LEGNLegend Biotech CorpSPONSORED ADS307,594$1,434 萬0.5%+307,594新進歷史
TNGXTango Therapeutics, Inc.COM1,300,000$1,422 萬0.5%00.0%不變歷史
ERASErasca, Inc.COM700,000$1,091 萬0.3%00.0%不變歷史
ARVNArvinas, Inc.COM130,300$1,070 萬0.3%+130,300新進歷史
CNTACentessa Pharmaceuticals plcSPONSORED ADS882,176$993.3 萬0.3%+127,631+16.9%加碼歷史
IMVTImmunovant, Inc.COM1,140,819$972.0 萬0.3%00.0%不變歷史
VYGRVoyager Therapeutics, Inc.COM3,557,507$964.1 萬0.3%+3,111,515+697.7%加碼歷史
NRIXNurix Therapeutics, Inc.COM309,540$896.1 萬0.3%−817,100−72.5%減碼歷史
LENZLENZ Therapeutics, Inc.COM688,900$856.3 萬0.3%+688,900新進歷史
SPRYARS Pharmaceuticals, Inc.COM1,060,010$706.0 萬0.2%−124,700−10.5%減碼歷史
CCCCC4 Therapeutics, Inc.COM STK200,000$644.0 萬0.2%00.0%不變歷史
FLACFrazier Lifesciences Acquisition CorpCL A SHS587,615$572.9 萬0.2%00.0%不變歷史
AMTIApplied Molecular Transport Inc.COM400,000$559.2 萬0.2%+400,000新進歷史
KRONKronos Bio, Inc.COM387,357$526.4 萬0.2%00.0%不變歷史
JYACJiya Acquisition Corp.COM CL A500,000$488.5 萬0.2%00.0%不變歷史
NGNENeurogene Inc.COM860,619$414.8 萬0.1%00.0%不變歷史
OBIOOrchestra BioMed Holdings, Inc.ORD SHS400,000$403.2 萬0.1%00.0%不變歷史
ACIUAC Immune SASHS749,585$371.0 萬0.1%−1,666−0.2%減碼歷史
VERVVerve Therapeutics, Inc.COM100,000$368.7 萬0.1%00.0%不變歷史
KNTEKinnate Biopharma Inc.COM175,000$310.1 萬0.1%00.0%不變歷史
DYNDyne Therapeutics, Inc.COM215,000$255.6 萬0.1%00.0%不變歷史
MLTXMoonLake ImmunotherapeuticsCOM CL A200,000$197.8 萬0.1%00.0%不變歷史
5 01 Acquisition Corp33836P105COM CL A200,000$197.0 萬0.1%00.0%不變–
BCLS Acquisition CorpG0904B105COM CL A200,000$196.0 萬0.1%00.0%不變–
Eucrates Biomedical Acqu CorG3141W106SHS200,000$195.2 萬0.1%00.0%不變–
ADVMAdverum Biotechnologies, Inc.COM1,046,700$184.2 萬0.1%+1,046,700新進歷史
ARYDARYA Sciences Acquisition Corp IVCL A150,000$148.7 萬<0.1%00.0%不變歷史
PMVPPMV Pharmaceuticals, Inc.COM50,000$115.5 萬<0.1%00.0%不變歷史
CRBUCaribou Biosciences, Inc.COM75,000$113.2 萬<0.1%00.0%不變歷史
ALGSAligos Therapeutics, Inc.COM91,044$108.1 萬<0.1%+91,044新進歷史
RPTXRepare Therapeutics Inc.COM50,000$105.5 萬<0.1%00.0%不變歷史
Turmeric Acquisition CorpG9127T108CL A100,000$98.2 萬<0.1%00.0%不變–
VTVTvTv Therapeutics Inc.CL A834,333$83.0 萬<0.1%+834,333新進歷史
GLUEMonte Rosa Therapeutics, Inc.COM37,593$76.8 萬<0.1%+37,593新進歷史
BOLTBolt Biotherapeutics, Inc.COM150,000$73.5 萬<0.1%00.0%不變歷史
PCVXVaxcyte, Inc.COM20,800$49.5 萬<0.1%+20,800新進歷史
Omega Alpha SpacG6749V107CL A50,000$48.9 萬<0.1%00.0%不變–
Nuvation Bio Inc.67080N119*W EXP 07/07/202963,333––00.0%不變–
Eucrates Biomedical Acqu CorG3141W122*W EXP 10/23/20266,666––00.0%不變–
Frazier Lifesciences Acqu CoG3710A113*W EXP 11/30/20266,665––00.0%不變–
Turmeric Acquisition CorpG9127T124*W EXP 10/08/20233,333––00.0%不變–
CareMax, Inc.14171W111*W EXP 06/08/202100,000––00.0%不變–
Surrozen, Inc.86889P117*W EXP 08/01/20366,665––00.0%不變–

選擇權(1 檔)

同一份申報裡的賣權(put)與買權(call)。金額是標的股票的市值,也就是 13F 申報的數字。

EcoR1 Capital, LLC 在 2021 年第 4 季的選擇權部位
證券類別賣權買權
GRTSGritstone bio, Inc.COM–$394.8 萬

2021 年第 3 季之後清倉(14 檔)

2021 年第 3 季季末還持有、這份申報已經沒有的部位。

EcoR1 Capital, LLC 在 2021 年第 3 季之後清倉的部位
證券類別2021 年第 3 季股數2021 年第 3 季市值2021 年第 3 季佔組合 %紀錄
MRTXMirati Therapeutics, Inc.COM464,298$8,214 萬2.9%歷史
STTKShattuck Labs, Inc.COM3,709,072$7,559 萬2.7%歷史
DRNADicerna Pharmaceuticals IncCOM1,249,812$2,520 萬0.9%歷史
BLUEbluebird bio, Inc.COM802,507$1,534 萬0.5%歷史
ODTOdonate Therapeutics, Inc.COM3,727,261$1,085 萬0.4%歷史
CRVSCorvus Pharmaceuticals, Inc.COM2,081,077$1,007 萬0.4%歷史
KRSAKorsana Biosciences, Inc.COM1,606,276$493.1 萬0.2%歷史
FS Development Corp II30318F100COM CL A371,014$369.2 萬0.1%–
IGMSIGM Biosciences, Inc.COM38,030$250.1 萬0.1%歷史
FMTXForma Therapeutics Holdings, Inc.SHS90,141$209.0 萬0.1%歷史
BCABBioAtla, Inc.COM50,000$147.2 萬0.1%歷史
MGTXMeiraGTx Holdings plcCOM94,819$125.0 萬<0.1%歷史
SRRKScholar Rock Holding CorpCOM8,208$27.1 萬<0.1%歷史
ALPNAlpine Immune Sciences, Inc.COM7,001$7.50 萬<0.1%歷史